The Division of Urology has advanced its research efforts through the development of an NIH-funded basic research laboratory that is housed in the RC2 Research Building on the Anschutz Medical campus of the University of Colorado. Directed by Hari K. Koul, PhD, this core facility will provide a pivotal resource for basic research in pediatric urology, voiding dysfunction, urinary stone disease, erectile dysfunction, urologic oncology, and minimally invasive approaches to urologic surgery.
Prior to his arrival at the University of Colorado School of Medicine, Dr. Koul was chief of the Signal Transduction Laboratory at the Vattikuti Urology Institute at Henry Ford Health Systems in Detroit, MI.
The goal of this laboratory is to understand the molecular mechanisms involved in pathologic conditions associated with the urogenital tract. A specific focus of the various studies is to understand the role of mitogen activated protein (MAP) kinase signal transduction pathways in development, physiology and pathophysiology of the urogenital system.
Research Staff Directory